Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Brandon Mcmahon

Concepts (259)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myeloproliferative Disorders
9
2022
27
1.420
Why?
Thrombosis
6
2019
366
1.400
Why?
Primary Myelofibrosis
3
2025
10
1.180
Why?
Urokinase-Type Plasminogen Activator
4
2015
29
1.020
Why?
Plasminogen Activator Inhibitor 1
3
2015
86
0.920
Why?
Thrombocytopenia
3
2016
198
0.890
Why?
Neoplasms
9
2021
2643
0.870
Why?
Pyrazoles
3
2025
423
0.840
Why?
Anticoagulants
5
2021
663
0.840
Why?
Hemorrhage
5
2018
721
0.810
Why?
Plasminogen
3
2013
30
0.730
Why?
Fibrinolysin
2
2013
19
0.710
Why?
Blood Platelets
3
2025
406
0.650
Why?
Receptors, Urokinase Plasminogen Activator
2
2015
15
0.540
Why?
Liver Cirrhosis
2
2020
316
0.510
Why?
Anemia, Pernicious
1
2016
9
0.510
Why?
Pancytopenia
1
2016
8
0.500
Why?
Hypothyroidism
1
2016
72
0.480
Why?
Neoplasm Proteins
2
2009
434
0.480
Why?
Myelodysplastic Syndromes
2
2016
134
0.470
Why?
Unnecessary Procedures
1
2014
50
0.430
Why?
Tissue Inhibitor of Metalloproteinase-2
1
2013
15
0.410
Why?
Heparin
1
2014
259
0.400
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
851
0.380
Why?
Thrombophilia
2
2009
83
0.370
Why?
Medical Oncology
5
2022
288
0.360
Why?
Polycythemia Vera
4
2022
12
0.350
Why?
Fibrinolysis
2
2009
143
0.340
Why?
Nitriles
2
2025
172
0.310
Why?
Interferon Type I
3
2015
141
0.300
Why?
Biomarkers, Tumor
2
2018
1272
0.300
Why?
Tissue Plasminogen Activator
2
2009
223
0.280
Why?
Tumor Necrosis Factor-alpha
2
2025
1242
0.270
Why?
Antineoplastic Agents
5
2018
2122
0.270
Why?
Pyrimidines
2
2025
470
0.260
Why?
Intracellular Signaling Peptides and Proteins
3
2015
455
0.250
Why?
Venous Thromboembolism
2
2021
313
0.250
Why?
Qa-SNARE Proteins
1
2025
20
0.240
Why?
Humans
38
2025
136765
0.230
Why?
Fetomaternal Transfusion
1
2023
11
0.210
Why?
Thrombocythemia, Essential
1
2022
7
0.200
Why?
Down-Regulation
1
2025
656
0.200
Why?
Autophagy
1
2025
280
0.200
Why?
Interferon-alpha
2
2014
198
0.200
Why?
MAP Kinase Signaling System
2
2015
320
0.180
Why?
Telomerase
2
2020
250
0.180
Why?
Graft vs Host Disease
1
2023
248
0.180
Why?
Venous Thrombosis
1
2021
190
0.160
Why?
Mastocytosis, Systemic
1
2018
8
0.150
Why?
Mutation
4
2020
3946
0.150
Why?
Treatment Outcome
6
2025
10745
0.150
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
53
0.150
Why?
Pregnancy Complications
1
2023
524
0.150
Why?
Chicago
2
2016
61
0.140
Why?
Eosinophilia
1
2020
218
0.140
Why?
Risk Factors
5
2021
10325
0.140
Why?
Gene Rearrangement
1
2018
149
0.140
Why?
Mitochondria
2
2025
946
0.140
Why?
Anaphylaxis
1
2018
105
0.140
Why?
Neovascularization, Pathologic
2
2009
301
0.130
Why?
Janus Kinase 2
2
2015
32
0.130
Why?
Aging
2
2019
1864
0.130
Why?
Aged, 80 and over
3
2025
7585
0.130
Why?
Neoplasm Metastasis
2
2009
657
0.130
Why?
Philadelphia Chromosome
1
2016
18
0.120
Why?
Biomarkers
3
2018
4144
0.120
Why?
Vitamin B 12 Deficiency
1
2016
81
0.120
Why?
Anemia, Iron-Deficiency
1
2016
58
0.120
Why?
Fusion Proteins, bcr-abl
1
2015
69
0.120
Why?
Vitamin B 12
1
2016
128
0.120
Why?
Thienamycins
1
2015
5
0.120
Why?
Inactivation, Metabolic
1
2015
11
0.120
Why?
Piperacillin
1
2015
9
0.120
Why?
Anemia, Hemolytic
1
2015
20
0.120
Why?
Vitamin K
1
2015
45
0.120
Why?
Age Factors
4
2015
3284
0.110
Why?
False Positive Reactions
1
2014
115
0.110
Why?
Aged
5
2025
23794
0.110
Why?
Cell Movement
2
2009
968
0.110
Why?
Hemostasis
1
2014
82
0.110
Why?
Bone Marrow Neoplasms
1
2013
3
0.110
Why?
Signal Transduction
4
2016
5076
0.110
Why?
Drug Hypersensitivity
1
2015
90
0.100
Why?
Patient Care Team
1
2018
626
0.100
Why?
Drug Monitoring
1
2015
218
0.100
Why?
Blood Transfusion
1
2016
323
0.100
Why?
Chi-Square Distribution
1
2014
530
0.100
Why?
Thrombocytosis
1
2012
6
0.100
Why?
Adult
10
2022
37631
0.100
Why?
Academic Medical Centers
1
2016
504
0.100
Why?
Leukocytosis
1
2012
30
0.100
Why?
Interferon-beta
1
2013
92
0.100
Why?
Pseudomonas Infections
1
2015
225
0.100
Why?
Middle Aged
6
2025
33228
0.100
Why?
Receptor, Interferon alpha-beta
1
2012
35
0.100
Why?
Female
10
2025
72795
0.100
Why?
Liver Transplantation
1
2020
871
0.100
Why?
Administration, Oral
1
2015
813
0.100
Why?
Annexin A2
2
2009
11
0.100
Why?
Antibodies
1
2014
411
0.100
Why?
Predictive Value of Tests
2
2015
2022
0.100
Why?
Kaplan-Meier Estimate
1
2014
888
0.090
Why?
Prognosis
3
2016
4013
0.090
Why?
Gene Expression Regulation, Neoplastic
2
2015
1396
0.090
Why?
Animals
9
2025
36847
0.090
Why?
Male
9
2025
67311
0.080
Why?
Respiratory Tract Infections
1
2015
394
0.080
Why?
RNA-Binding Proteins
1
2014
423
0.080
Why?
Mice
7
2025
17757
0.080
Why?
Phosphoproteins
1
2012
337
0.080
Why?
Apoptosis
2
2009
2551
0.080
Why?
Leukemia, Myeloid, Acute
1
2016
622
0.080
Why?
Carrier Proteins
1
2014
769
0.080
Why?
Nuclear Proteins
1
2014
712
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2009
11
0.080
Why?
Cryoglobulins
1
2009
6
0.080
Why?
Carboxypeptidase B2
1
2009
3
0.080
Why?
Plasminogen Inactivators
1
2009
3
0.080
Why?
Receptors, Peptide
1
2009
17
0.080
Why?
Anemia, Hemolytic, Autoimmune
1
2009
14
0.080
Why?
Blood Group Antigens
1
2009
15
0.080
Why?
Cerebral Infarction
1
2009
43
0.080
Why?
Factor VII
1
2008
24
0.080
Why?
Edetic Acid
1
2008
50
0.080
Why?
Disease Progression
3
2015
2750
0.070
Why?
Nerve Tissue Proteins
1
2012
595
0.070
Why?
von Willebrand Factor
1
2008
80
0.070
Why?
Multiple Organ Failure
1
2009
127
0.070
Why?
Inflammation
1
2019
2835
0.070
Why?
Factor VIII
1
2008
98
0.070
Why?
Time Factors
2
2018
6808
0.070
Why?
Oncogene Proteins, Fusion
2
2020
214
0.070
Why?
Immunoglobulin M
1
2009
289
0.070
Why?
Transcription, Genetic
1
2014
1455
0.070
Why?
Neoplasm Invasiveness
1
2009
507
0.070
Why?
Bone Marrow
2
2018
286
0.070
Why?
Practice Patterns, Physicians'
1
2016
1301
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
382
0.070
Why?
Cell Division
1
2009
796
0.070
Why?
Blood Coagulation Disorders
1
2009
172
0.070
Why?
Membrane Proteins
1
2012
1163
0.060
Why?
Intestines
1
2009
357
0.060
Why?
Ischemia
1
2009
407
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2023
614
0.060
Why?
Cytokines
2
2014
2084
0.060
Why?
Retrospective Studies
4
2016
15504
0.060
Why?
Cystic Fibrosis
1
2015
1108
0.060
Why?
Biopsy
2
2018
1124
0.060
Why?
Janus Kinases
2
2016
15
0.060
Why?
Anti-Bacterial Agents
1
2015
1797
0.060
Why?
Erythroid Cells
2
2015
10
0.060
Why?
Societies, Medical
2
2018
816
0.060
Why?
Molecular Targeted Therapy
2
2018
411
0.050
Why?
Immunosuppressive Agents
1
2009
889
0.050
Why?
Hepatitis B virus
1
2003
40
0.050
Why?
Mice, Knockout
2
2025
3008
0.050
Why?
Virus Integration
1
2003
71
0.050
Why?
p38 Mitogen-Activated Protein Kinases
2
2015
283
0.050
Why?
Papillomaviridae
1
2003
126
0.050
Why?
Antibodies, Monoclonal
1
2009
1430
0.050
Why?
Survival Analysis
2
2018
1321
0.040
Why?
Protein Kinase Inhibitors
2
2018
916
0.040
Why?
Autoantibodies
1
2009
1496
0.040
Why?
Combined Modality Therapy
2
2017
1231
0.040
Why?
Uterine Cervical Neoplasms
1
2003
254
0.040
Why?
Hematopoietic Stem Cells
2
2014
402
0.040
Why?
Megakaryocytes
1
2019
34
0.040
Why?
Phosphorylation
2
2014
1758
0.040
Why?
Histamine Antagonists
1
2018
21
0.040
Why?
mRNA Cleavage and Polyadenylation Factors
1
2018
29
0.040
Why?
Platelet Activation
1
2019
93
0.040
Why?
Fetus
1
2023
806
0.040
Why?
Glomerulonephritis, IGA
1
2018
11
0.040
Why?
Proto-Oncogene Proteins c-kit
1
2018
67
0.040
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2018
44
0.040
Why?
Fibroblasts
2
2014
993
0.040
Why?
Transplantation, Homologous
1
2018
415
0.030
Why?
Mast Cells
1
2018
147
0.030
Why?
Immunophenotyping
1
2018
319
0.030
Why?
Prevalence
2
2015
2710
0.030
Why?
Liver Neoplasms
1
2003
785
0.030
Why?
Receptors, Thrombopoietin
1
2016
6
0.030
Why?
Thrombopoietin
1
2016
5
0.030
Why?
Cell Line, Tumor
2
2015
3405
0.030
Why?
Cells, Cultured
2
2015
4191
0.030
Why?
Benzoates
1
2016
43
0.030
Why?
Drug Administration Schedule
1
2018
785
0.030
Why?
Hydrazines
1
2016
35
0.030
Why?
Antimetabolites, Antineoplastic
1
2016
94
0.030
Why?
Receptors, Fc
1
2016
53
0.030
Why?
General Practice
1
2016
29
0.030
Why?
Platelet Count
1
2015
85
0.030
Why?
Drug Therapy, Combination
1
2018
1062
0.030
Why?
Autophagy-Related Protein-1 Homolog
1
2015
7
0.030
Why?
Azacitidine
1
2016
140
0.030
Why?
Immunologic Tests
1
2015
16
0.030
Why?
Interferon Regulatory Factors
1
2015
38
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
535
0.030
Why?
Response Elements
1
2015
91
0.030
Why?
Nuclear Cap-Binding Protein Complex
1
2014
1
0.030
Why?
Medication Adherence
1
2018
466
0.030
Why?
Patient Selection
1
2018
690
0.030
Why?
Ubiquitins
1
2014
36
0.030
Why?
Ribosomal Protein S6 Kinases, 90-kDa
1
2014
14
0.030
Why?
Guanosine
1
2014
41
0.030
Why?
Interferons
1
2016
202
0.030
Why?
Rapamycin-Insensitive Companion of mTOR Protein
1
2014
28
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2052
0.030
Why?
Health Care Surveys
1
2016
562
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2014
121
0.030
Why?
Risk
1
2016
908
0.030
Why?
Recombinant Fusion Proteins
1
2016
664
0.030
Why?
Microbial Sensitivity Tests
1
2015
357
0.030
Why?
Mutation, Missense
1
2015
337
0.030
Why?
Eukaryotic Initiation Factor-4E
1
2013
27
0.030
Why?
Cell Line, Transformed
1
2013
145
0.030
Why?
U937 Cells
1
2012
24
0.030
Why?
Gene Knockdown Techniques
1
2014
327
0.020
Why?
Randomized Controlled Trials as Topic
1
2018
1462
0.020
Why?
Aspirin
1
2015
387
0.020
Why?
Multivariate Analysis
1
2016
1507
0.020
Why?
Embryo, Mammalian
1
2012
232
0.020
Why?
Hospitalists
1
2016
245
0.020
Why?
Patient Outcome Assessment
1
2013
131
0.020
Why?
Epigenesis, Genetic
1
2016
657
0.020
Why?
Logistic Models
1
2016
2067
0.020
Why?
Pregnancy
1
2023
6726
0.020
Why?
Leukemia
1
2013
238
0.020
Why?
Vascular Diseases
1
2013
243
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2012
428
0.020
Why?
Splanchnic Circulation
1
2009
10
0.020
Why?
Infarction
1
2009
10
0.020
Why?
Plasmapheresis
1
2009
24
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
86
0.020
Why?
Antibody Specificity
1
2009
189
0.020
Why?
Blood Specimen Collection
1
2008
40
0.020
Why?
Giant Cell Arteritis
1
2009
49
0.020
Why?
Mice, Inbred C57BL
1
2019
5749
0.020
Why?
Tretinoin
1
2009
123
0.020
Why?
Fatal Outcome
1
2009
303
0.020
Why?
Immunoassay
1
2008
113
0.020
Why?
Rituximab
1
2009
176
0.020
Why?
Risk Assessment
1
2017
3432
0.020
Why?
Plasma
1
2008
212
0.020
Why?
Spleen
1
2009
514
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
1682
0.020
Why?
Hospitalization
1
2016
2182
0.020
Why?
Internship and Residency
1
2016
1132
0.020
Why?
Cell Differentiation
1
2013
1982
0.010
Why?
Cross-Sectional Studies
1
2016
5423
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2003
283
0.010
Why?
Tumor Cells, Cultured
1
2003
953
0.010
Why?
United States
1
2018
14690
0.010
Why?
Kidney
1
2009
1467
0.010
Why?
Liver
1
2009
1940
0.010
Why?
Base Sequence
1
2003
2179
0.010
Why?
Molecular Sequence Data
1
2003
2894
0.010
Why?
Adolescent
1
2015
21382
0.010
Why?
DNA-Binding Proteins
1
2003
1501
0.010
Why?
Mcmahon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)